Allosteric modulators hit the TSH receptor.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1210/en.2013-2079PMID 24364583PMCID PMC3868806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice.

  2014cited by this paper
• Molecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonists

  2013cited by this paper
• Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.

  2012cited by this paper
• Extended and Structurally Supported Insights into Extracellular Hormone Binding, Signal Transduction and Organization of the Thyrotropin Receptor

  2012cited by this paper
• Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid‐stimulating hormone receptor

  2012cited by this paper
• G-protein-coupled receptors signal victory.

  2012cited by this paper
• Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor

  2012cited by this paper
• Restructuring G-protein- coupled receptor activation.

  2012cited by this paper
• A Drug-Like Antagonist Inhibits Thyrotropin Receptor–Mediated Stimulation of cAMP Production in Graves' Orbital Fibroblasts

  2012cited by this paper
• Small molecule TSHR agonists and antagonists.

  2011influential reference
• A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy

  2011cited by this paper
• Tissue-specific knockout of TSHr in white adipose tissue increases adipocyte size and decreases TSH-induced lipolysis.

  2010cited by this paper
• Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor

  2010cited by this paper
• Signaling‐sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor

  2010cited by this paper
• Signaling by internalized G-protein-coupled receptors.

  2010cited by this paper
• A Stimulatory Thyrotropin Receptor Antibody (M22) and Thyrotropin Increase Interleukin-6 Expression and Secretion in Graves' Orbital Preadipocyte Fibroblasts

  2010cited by this paper
• Graves' ophthalmopathy.

  2010cited by this paper
• Subunit interactions influence TSHR multimerization.

  2010cited by this paper
• The Superagonistic Activity of Bovine Thyroid-stimulating Hormone (TSH) and the Human TR1401 TSH Analog Is Determined by Specific Amino Acids in the Hinge Region of the Human TSH Receptor*

  2009cited by this paper
• Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.

  2009cited by this paper
• Targeting cancer with small molecule kinase inhibitors

  2009cited by this paper
• A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism.

  2008cited by this paper
• A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor

  2008cited by this paper
• TSH Receptor Blocking Antibodies

  2008cited by this paper
• Crystal Structure of the TSH Receptor in Complex with a Thyroid-Stimulating Autoantibody

  2007cited by this paper
• Pathogenesis of Graves' Ophthalmopathy: The Role of Autoantibodies

  2007cited by this paper
• A Low Molecular Weight Agonist Signals by Binding to the Transmembrane Domain of Thyroid-stimulating Hormone Receptor (TSHR) and Luteinizing Hormone/Chorionic Gonadotropin Receptor (LHCGR)*

  2006cited by this paper
• Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity

  2005cited by this paper
• Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

  2005cited by this paper
• TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves’ ophthalmopathy

  2004cited by this paper
• Activating Mutations of the TSH Receptor

  2004cited by this paper
• TSH is a negative regulator of skeletal remodeling.

  2003cited by this paper
• Thyrotropin Receptor Expression in Orbital Adipose/Connective Tissues from Patients with Thyroid-Associated Ophthalmopathy

  2002cited by this paper
• The TSH receptor reveals itself.

  2002cited by this paper
• Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice

  2002cited by this paper
• Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?

  2002cited by this paper
• Oligomerization of the Human Thyrotropin Receptor

  2001cited by this paper
• Subunit Structure of Thyrotropin Receptors Expressed on the Cell Surface*

  1999cited by this paper
• The shed thyrotropin receptor is primarily a carboxyl terminal truncated form of the A subunit, not the entire A subunit.

  1999cited by this paper
• Increased sulfatation of orbital glycosaminoglycans in Graves' ophthalmopathy.

  1999cited by this paper
• The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies

  1998cited by this paper
• The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies.

  1998cited by this paper
• Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.

  1997cited by this paper
• Graves' ophthalmopathy.

  1992cited by this paper
• Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells.

  1991cited by this paper
• Lignin and bile acid binding.

  1981cited by this paper
• THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE

  1974cited by this paper
• Thyroid-stimulating immunoglobulins in Graves' disease.

  1974cited by this paper

• Thyroid Stem Cell Speciation - A Major Role for PKC.

  2023cites this paper
• Thyrotropin receptor antagonists and inverse agonists, and their potential application to thyroid diseases.

  2022cites this paper
• Structure of full-length TSH receptor in complex with antibody K1-70™

  2022cites this paper
• Thyroid-Stimulating Hormone Receptor: the Role in the Development of Thyroid Pathology and Its Correction

  2022influential citation
• Glycosylation pattern analysis of glycoprotein hormones and their receptors.

  2017cites this paper
• Maternal Macronutrient Consumption and the Developmental Origins of Metabolic Disease in the Offspring

  2017cites this paper
• The “TSH Receptor Glo Assay” – A High-Throughput Detection System for Thyroid Stimulation

  2016cites this paper
• Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies

  2015cites this paper
• Mechanisms of Action of TSHR Autoantibodies

  2015cites this paper
• Leydig cell aging and hypogonadism.

  2015cites this paper
• New Small Molecule Agonists to the Thyrotropin Receptor

  2015cites this paper
• Molecular Insights into the Transmembrane Domain of the Thyrotropin Receptor

  2015cites this paper
• Leydig Cells: Fetal to Aged Testes

  2014cites this paper
• Licensee Oapl (uk) 2014. Creative Commons Attribution License (cc-by) Freedom of Expression beyond the Thyroid: the Thyroid- Stimulating Hormone Receptor in the Adipocyte

  year unknowncites this paper